Evidence map›Paper›PMID 37147643›Full record

Trial reportImplementation science : IS2023

SciComm Optimizer for Policy Engagement: a randomized controlled trial of the SCOPE model on state legislators' research use in public discourse.

J Taylor Scott, K Megan Collier, Jessica Pugel, Patrick O'Neill, Elizabeth C Long, Mary A Fernandes, Katherine Cruz, Brittany Gay, Cagla Giray, D Max Crowley

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Implementation science : IS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Insight for knowledge brokers: factors predicting relationships with federal staffers.Evidence & policy : a journal of research, debate and practice · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

J Taylor ScottEvidence-to-Impact Collaborative, The Pennsylvania State University, State College, USA. jxs1622@psu.edu.ORCID 0000-0003-1827-4723
K Megan CollierSocial Work Department, Boston College, Chestnut Hill, USA.
Jessica PugelEvidence-to-Impact Collaborative, The Pennsylvania State University, State College, USA.
Patrick O'NeillPsychology Department, Teachers College at Columbia University, New York City, USA.
Elizabeth C LongEvidence-to-Impact Collaborative, The Pennsylvania State University, State College, USA.
Mary A FernandesDepartment of Psychology, Georgia State University, Atlanta, USA.
Katherine CruzDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.
Brittany GayEvidence-to-Impact Collaborative, The Pennsylvania State University, State College, USA.
Cagla GirayCenter for Health Security, John Hopkins Bloomberg School of Public Health, Baltimore, USA.
D Max CrowleyEvidence-to-Impact Collaborative, The Pennsylvania State University, State College, USA.
Pennsylvania State University · USJohns Hopkins University · USBoston College · USColumbia University · USGeorgia State University · US

Funding

STRATIFIED CLUSTER RANDOMIZED TRIAL (SCRT) OF A CLINICAL DECISION RULE (CDR) FOR ABUSIVE HEAD TRAUMA (AHT)P50HD089922 · NICHD · PENNSYLVANIA STATE UNIVERSITY, THE · PI CHRISTIAN M CONNELL · 2017 to 2026
$16.9M
NICHD NIH HHS P50 HD089922
6 · The paper itself

Abstract

backgroundWhile prior work has revealed conditions that foster policymakers' use of research evidence, few studies have rigorously investigated the effectiveness of theory-based practices. Specifically, policymakers are most apt to use research evidence when it is timely, relevant, brief, and messaged appropriately, as well as when it facilitates interactive engagement. This study sought to experimentally evaluate an enhanced research dissemination intervention, known as the SciComm Optimizer for Policy Engagement (SCOPE), implemented during the COVID-19 pandemic among US state legislators.

methodsState legislators assigned to health committees and their staff were randomized to receive the SCOPE intervention. This involved providing academic researchers with a pathway for translating and disseminating research relevant to current legislative priorities via fact sheets emailed directly to officials. The intervention occurred April 2020-March 2021. Research language was measured in state legislators' social media posts.

resultsLegislators randomized to receive the intervention, relative to the control group, produced 24% more social media posts containing research language related to COVID-19. Secondary analyses revealed that these findings were driven by two different types of research language. Intervention officials produced 67% more COVID-related social media posts referencing technical language (e.g., statistical methods), as well as 28% more posts that referenced research-based concepts. However, they produced 31% fewer posts that referenced creating or disseminating new knowledge.

conclusionsThis study suggests that strategic, targeted science communication efforts may have the potential to change state legislators' public discourse and use of evidence. Strategic science communication efforts are particularly needed in light of the role government officials have played in communicating about the pandemic to the general public.

Indexed as

COVID-19CommunicationHumansPandemicsPolicyResearchDisseminationPolicymakingResearch translationScience communicationUse of research evidence

Identifiers

PMID37147643
PMCPMC10160730
OpenAlexW4372332184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.